Search research articles
Contact Us
Filters
Showing results (31-40 of 139) with videos related to
Page
of 14
Sort By:
Circulation
|
August 17, 2005
Should aspirin be discontinued before coronary artery bypass surgery?
Jack C J Sun, Mark A Crowther, Theodore E Warkentin, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
January 19, 2019
The cost implication of primary prevention in the HOPE 3 trial
Andre Lamy, Eva Lonn, Wesley Tong, et al.
The Canadian Journal of Cardiology
|
April 3, 2009
Para-aortic arch abscess secondary to Staphylococcus aureus pneumonia
Karen K Koo, Jack C J Sun, Richard P Whitlock, et al.
Anesthesia and Analgesia
|
September 1, 2017
Tranexamic Acid Administration During On-Pump Cardiac Surgery: A Survey of Current Practices Among Canadian Anesthetists Working in Academic Centers
Jessica Spence, Steven Long, Antonella Tidy, et al.
Journal of the American College of Cardiology
|
March 16, 2005
Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation
William S Weintraub, Elizabeth M Mahoney, Andre Lamy, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
December 12, 2018
Steroids in cardiac surgery trial: a substudy of surgical site infections
Graham R McClure, Emilie P Belley-Cote, John Harlock, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
August 9, 2020
Feasibility of studying the association between intraoperative regional cerebral oxygen saturation and postoperative functional decline (ReFUNCTION): a pilot sub-study of NeuroVISION-Cardiac Surgery
Jessica Spence, Andre Lamy, Jackie Bosch, et al.
JTCVS Open
|
January 9, 2025
RBT-1 reduces blood product utilization in patients undergoing nonemergency coronary artery bypass grafting and/or valve surgery
Charles A Mack, Michael Jessen, Andre Lamy, et al.
Journal of the American Heart Association
|
May 31, 2021
New-Onset Perioperative Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Risk of Adverse Events: An Analysis From the CORONARY Trial
David Conen, Michael K Wang, P J Devereaux, et al.
Journal of Medical Economics
|
October 11, 2011
The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study
Andre Lamy, Xiaoyin Wang, Peggy Gao, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 139) with videos related to
Sort By:
Page
of 14
Circulation
|
August 17, 2005
Should aspirin be discontinued before coronary artery bypass surgery?
Jack C J Sun, Mark A Crowther, Theodore E Warkentin, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
January 19, 2019
The cost implication of primary prevention in the HOPE 3 trial
Andre Lamy, Eva Lonn, Wesley Tong, et al.
The Canadian Journal of Cardiology
|
April 3, 2009
Para-aortic arch abscess secondary to Staphylococcus aureus pneumonia
Karen K Koo, Jack C J Sun, Richard P Whitlock, et al.
Anesthesia and Analgesia
|
September 1, 2017
Tranexamic Acid Administration During On-Pump Cardiac Surgery: A Survey of Current Practices Among Canadian Anesthetists Working in Academic Centers
Jessica Spence, Steven Long, Antonella Tidy, et al.
Journal of the American College of Cardiology
|
March 16, 2005
Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation
William S Weintraub, Elizabeth M Mahoney, Andre Lamy, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
December 12, 2018
Steroids in cardiac surgery trial: a substudy of surgical site infections
Graham R McClure, Emilie P Belley-Cote, John Harlock, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
August 9, 2020
Feasibility of studying the association between intraoperative regional cerebral oxygen saturation and postoperative functional decline (ReFUNCTION): a pilot sub-study of NeuroVISION-Cardiac Surgery
Jessica Spence, Andre Lamy, Jackie Bosch, et al.
JTCVS Open
|
January 9, 2025
RBT-1 reduces blood product utilization in patients undergoing nonemergency coronary artery bypass grafting and/or valve surgery
Charles A Mack, Michael Jessen, Andre Lamy, et al.
Journal of the American Heart Association
|
May 31, 2021
New-Onset Perioperative Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Risk of Adverse Events: An Analysis From the CORONARY Trial
David Conen, Michael K Wang, P J Devereaux, et al.
Journal of Medical Economics
|
October 11, 2011
The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study
Andre Lamy, Xiaoyin Wang, Peggy Gao, et al.
Page
of 14